Inclusion completed

Pazopanib in Advanced GISTs Refractory to Imatinib and Sunitinib - A Non-comparative Phase II Multicenter Study by the Scandinavian Sarcoma Group

Cancer type: Sarcoma

Phase: II

Principal Investigator: Golpen Dorota

Country: NO

Keywords: Norway, Bergen

Status: Inclusion completed

Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01524848